Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CLSK vs GSK✓SelectedUSD · GSKCLSK vs GSK performance historyLatest closeAs of-16.27%11/20
Stock and ETF performance explorer

CLSK vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-86.0%
GSK return
+96.4%
Excess return
-182.4%
Maximum drawdown
-98.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-16.3%-0.1%-16.1%-16.3%
7D-26.5%-5.3%-21.1%-26.7%
30D-44.1%-3.7%-40.5%-44.1%
3M-61.2%-7.3%-53.9%-61.2%
6M-68.2%-4.2%-64.0%-68.3%
YTD-51.7%+0.9%-52.5%-51.7%
1Y-50.0%+7.3%-57.3%-50.1%
3Y+6.5%+52.7%-46.2%+4.5%
5Y-72.8%+40.1%-112.9%-73.8%
10Y-86.0%+98.7%-184.7%-78.8%
All-86.0%+96.4%-182.4%-79.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling